tiprankstipranks
Advertisement
Advertisement

Directa Plus Funding Facility with Institutional Investor Falls Through

Story Highlights
  • Directa Plus says its planned funding facility cannot move forward with the institutional investor after recent developments.
  • The loss of the anticipated facility raises uncertainty over Directa Plus’s near-term financing and may force it to seek alternative capital sources.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Directa Plus Funding Facility with Institutional Investor Falls Through

Claim 55% Off TipRanks

The latest update is out from Directa Plus ( (GB:DCTA) ).

Directa Plus has disclosed that the proposed funding facility first announced at the end of March cannot currently be progressed with the institutional investor involved, following developments disclosed on 13 April. The company said it will provide further updates in due course, leaving uncertainty over near-term financing options and potentially affecting its funding strategy and growth plans.

The setback on the anticipated facility may prompt Directa Plus to explore alternative sources of capital as it seeks to support operations and commercialisation of its graphene-based technologies. Investors and other stakeholders are likely to focus on the company’s next steps in securing funding, given its ambitions in advanced materials and its positioning within the green economy space.

Spark’s Take on DCTA Stock

According to Spark, TipRanks’ AI Analyst, DCTA is a Neutral.

The score is held back primarily by weak financial performance (declining revenues, continued losses, and negative free cash flow). Technicals are supportive with strong trend signals but tempered by an overbought RSI. The latest earnings call was constructive (revenue growth, cost reduction, automation and partnerships), while valuation remains challenged due to ongoing losses and no dividend support.

To see Spark’s full report on DCTA stock, click here.

More about Directa Plus

Directa Plus is an Italy-based producer and supplier of graphene-based materials for consumer and industrial markets, listed on London’s AIM since 2016 and holder of the Green Economy Mark. Using proprietary plasma super expansion technology, it turns natural graphite into sustainable, non-toxic graphene nanoplatelets and G+ branded products in various forms for multiple applications.

Average Trading Volume: 132,333

Technical Sentiment Signal: Strong Sell

Current Market Cap: £7.05M

For an in-depth examination of DCTA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1